-449 C>G polymorphism of NFKB1 gene, coding nuclear factor-kappa-B, is associated with the susceptibility to ulcerative colitis

World Journal of Gastroenterology

Volumn 18, Issue 47, 2012, Pages 6981-6986

  Hayashi, Ranji ^a   Tahara, Tomomitsu ^a   Yamaaki, Tsukasa ^a   Saito, Takashi ^a   Matsunaga, Kazuhiro ^a   Hayashi, Nobuhiko ^a   Fukumura, Atsushi ^a   Ozaki, Kazuaki ^a   Nakamura, Masakatsu ^a   Shiroeda, Hisakazu ^a   Tsutsumi, Mikihiro ^a   Shibata, Tomoyuki ^b   Arisawa, Tomiyasu ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Genetic polymorphism; NFKB1; Ulcerative colitis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPING TECHNIQUE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR FACTOR KAPPA B GENE; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; ULCERATIVE COLITIS;

EID: 84873899592     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i47.6981     Document Type: Article

References (34)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-429
2. Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, Bui TH, Giovannini M, Zaehringer U, PenardLacronique V, Sansonetti PJ, Hugot JP, Thomas G. Geneenvironment interaction modulated by allelic heterogeneity in Inflammatory diseases. Proc Natl Acad Sci USA 2003; 100: 3455-3460
3. Head KA, Jurenka JS. Inflammatory bowel disease Part 1: ulcerative colitis--pathophysiology and conventional and alternative treatment options. Altern Med Rev 2003; 8: 247-283
4. Lakatos PL, Fischer S, Lakatos L, Gal I, Papp J. Current concept on the pathogenesis of inflammatory bowel diseasecrosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll"? World J Gastroenterol 2006; 12: 1829-1841
5. Newman B, Siminovitch KA. Recent advances in the genetics of Inflammatory bowel disease. Curr Opin Gastroenterol 2005; 21: 401-407
6. Wang F, Tahara T, Arisawa T, Shibata T, Nakamura M, Fujita H, Iwata M, Kamiya Y, Nagasaka M, Takahama K, Watanabe M, Hirata I, Nakano H. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis. J Gastroenterol Hepatol 2007; 22: 925-929
7. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Nakamura M, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol 2008; 28: 44-49
8. Shiroeda H, Tahara T, Nakamura M, Shibata T, Nomura T, Yamada H, Hayashi R, Saito T, Yamada M, Fukuyama T, Otsuka T, Yano H, Ozaki K, Tsuchishima M, Tsutsumi M, Arisawa T. Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan. Cytokine 2010; 51: 173-177
9. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Yonemura J, Kamiya Y, Ishizuka T, Nakagawa Y, Nagasaka M, Iwata M, Yamada H, Hirata I, Arisawa T. Association study of common genetic variants in pre-microRNAs in patients with ulcerative colitis. J Clin Immunol 2011; 31: 69-73
10. Cho JH, Nicolae DL, Gold LH, Fields CT, LaBuda MC, Rohal PM, Pickles MR, Qin L, Fu Y, Mann JS, Kirschner BS, Jabs EW, Weber J, Hanauer SB, Bayless TM, Brant SR. Identifcation of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci USA 1998; 95: 7502-7507
11. Le Beau MM, Ito C, Cogswell P, Espinosa R, Fernald AA, Baldwin AS. Chromosomal localization of the genes encoding the p50/p105 subunits of NF-kappa B (NFKB2) and the I kappa B/MAD-3 (NFKBI) inhibitor of NF-kappa B to 4q24 and 14q13, respectively. Genomics 1992; 14: 529-531
12. Neurath MF, Becker C, Barbulescu K. Role of NF-kappaB in immune and Inflammatory responses in the gut. Gut 1998; 43: 856-860
13. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor kappa B inflammatory bowel disease. Gut 1998; 42: 477-484
14. Zou YF, Wang F, Feng XL, Tao JH, Zhu JM, Pan FM, Su H. Association of NFKB1 -94ins/delATTG promoter polymorphism with susceptibility to autoimmune and Inflammatory diseases: a meta-analysis. Tissue Antigens 2011; 77: 9-17
15. Arisawa T, Tahara T, Shiroeda H, Yamada H, Nomura T, Hayashi R, Saito T, Fukuyama T, Otsuka T, Nakamura M, Toshikuni N, Tsuchishima M, Shibata T. NFKB1 polymorphism is associated with age-related gene methylation in Helicobacter pylori-infected subjects. Int J Mol Med 2012; 30: 255-262
16. Podolsky DK. Inflammatory bowel disease (2) N Engl J Med 1991; 325: 1008-1016
17. Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107: 3-11
18. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Hasegawa S, Takagi T, Wang FY, Hirata I, Nakano H. The relationship between Helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritis. Int J Mol Med 2007; 19: 143-148
19. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, Silverberg MS, Duerr RH, Cho JH, Gregersen PK, Wu Y, Achkar JP, Dassopoulos T, Mezey E, Bayless TM, Nouvet FJ, Brant SR. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004; 13: 35-45
20. Kurylowicz A, Hiromatsu Y, Jurecka-Lubieniecka B, Kula D, Kowalska M, Ichimura M, Koga H, Kaku H, Barandziak E, Nauman J, Jarzab B, Ploski R, Bednarczuk T. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease. Genes Immun 2007; 8: 532-538
21. Pereira SG, Oakley F. Nuclear factor-kappaB1: regulation and function. Int J Biochem Cell Biol 2008; 40: 1425-1430
22. Lin L, DeMartino GN, Greene WC. Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell 1998; 92: 819-828
23. de Winther MP, Kanters E, Kraal G, Hofker MH. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 2005; 25: 904-914
24. Perkins ND. Integrating cell-signalling pathways with NFkappaB and IKK function. Nat Rev Mol Cell Biol 2007; 8: 49-62
25. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008; 132: 344-362
26. Gadjeva M, Tomczak MF, Zhang M, Wang YY, Dull K, Rogers AB, Erdman SE, Fox JG, Carroll M, Horwitz BH. A role for NF-kappa B subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock. J Immunol 2004; 173: 5786-5793
27. Han W, Joo M, Everhart MB, Christman JW, Yull FE, Blackwell TS. Myeloid cells control termination of lung inflammation through the NF-kappaB pathway. Am J Physiol Lung Cell Mol Physiol 2009; 296: L320-L327
28. Borm ME, van Bodegraven AA, Mulder CJ, Kraal G, Bouma G. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Int J Immunogenet 2005; 32: 401-405
29. Mirza MM, Fisher SA, Onnie C, Lewis CM, Mathew CG, Sanderson J, Forbes A. No association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohort. Gut 2005; 54: 1205-1206
30. Oliver J, Gómez-García M, Paco L, López-Nevot MA, Piñero A, Correro F, Martín L, Brieva JA, Nieto A, Martín J. A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population. Infamm Bowel Dis 2005; 11: 576-579
31. Latiano A, Palmieri O, Valvano MR, Bossa F, Latiano T, Corritore G, DeSanto E, Andriulli A, Annese V. Evaluating the role of the genetic variations of PTPN22, NFKB1, and FcGRIIIA genes in inflammatory bowel disease: a metaanalysis. Infamm Bowel Dis 2007; 13: 1212-1219
32. Andersen V, Christensen J, Ernst A, Jacobsen BA, Tjønneland A, Krarup HB, Vogel U. Polymorphisms in NF B, PXR, LXR, PPARγ and risk of Inflammatory bowel disease. World J Gastroenterol 2011; 17: 197-206
33. Cho JH, Brant SR. Genetics and genetic markers in IBD. Curr Opin Gastroenterol 1998; 14: 283-288
34. Fisher SA, Hampe J, Macpherson AJ, Forbes A, LennardJones JE, Schreiber S, Curran ME, Mathew CG, Lewis CM. Sex stratifcation of an Inflammatory bowel disease genome search shows male-specific linkage to the HLA region of chromosome 6. Eur J Hum Genet 2002; 10: 259-265